Home LiteratureArticle Details
PMID: 16891172 Published · ppublish English Journal Article Research Support, N.I.H., Intramural Review

Repair of topoisomerase I-mediated DNA damage.

Progress in nucleic acid research and molecular biology ·Vol. 81 ·2006-00-00 ·Pages 179-229

Pommier Y, Barcelo JM, Rao VA, Sordet O, Jobson AG, Thibaut L, Miao ZH, Seiler JA, Zhang H, Marchand C, Agama K, Nitiss JL, Redon C

Abstract

暂无摘要

MeSH Terms
Animals Antineoplastic Agents/pharmacology Catalysis DNA Damage/genetics DNA Repair/physiology DNA Topoisomerases, Type I/metabolism Enzyme Stability/drug effects Humans
Chemicals
Antineoplastic Agents DNA Topoisomerases, Type I
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Pommier Yves
Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, Maryland 20892, USA.
Barcelo Juana M
Rao V Ashutosh
Sordet Olivier
Jobson Andrew G
Thibaut Laurent
Miao Ze-Hong
Seiler Jennifer A
Zhang Hongliang
Marchand Christophe
Agama Keli
Nitiss John L
Redon Christophe
References (250)
250 references, click to expand
  1. The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin.
    Nat Genet. 2001 Oct;29(2):189-93 PMID: 11586300
  2. The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily.
    Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12009-14 PMID: 11572945
  3. Transcriptional consequences of topoisomerase inhibition.
    Mol Cell Biol. 2001 Dec;21(24):8437-51 PMID: 11713279
  4. Genes required for ionizing radiation resistance in yeast.
    Nat Genet. 2001 Dec;29(4):426-34 PMID: 11726929
  5. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress.
    J Biol Chem. 2001 Dec 21;276(51):47759-62 PMID: 11673449
  6. S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function.
    J Biol Chem. 2002 Jan 11;277(2):1599-606 PMID: 11700302
  7. DNA topoisomerases: structure, function, and mechanism.
    Annu Rev Biochem. 2001;70:369-413 PMID: 11395412
  8. X-ray repair cross-complementing gene I protein plays an important role in camptothecin resistance.
    Cancer Res. 2002 Jan 15;62(2):459-65 PMID: 11809696
  9. MMS1 protects against replication-dependent DNA damage in Saccharomyces cerevisiae.
    Mol Genet Genomics. 2002 Jan;266(5):848-57 PMID: 11810260
  10. Pnk1, a DNA kinase/phosphatase required for normal response to DNA damage by gamma-radiation or camptothecin in Schizosaccharomyces pombe.
    J Biol Chem. 2002 Feb 8;277(6):4050-5 PMID: 11729194
  11. Werner and Bloom helicases are involved in DNA repair in a complementary fashion.
    Oncogene. 2002 Jan 31;21(6):954-63 PMID: 11840341
  12. The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1.
    Structure. 2002 Feb;10(2):237-48 PMID: 11839309
  13. Processing of nucleopeptides mimicking the topoisomerase I-DNA covalent complex by tyrosyl-DNA phosphodiesterase.
    Nucleic Acids Res. 2002 Mar 1;30(5):1198-204 PMID: 11861912
  14. PARP determines the mode of cell death in skin fibroblasts, but not keratinocytes, exposed to sulfur mustard.
    J Invest Dermatol. 2001 Dec;117(6):1566-73 PMID: 11886524
  15. Histone H2A variants H2AX and H2AZ.
    Curr Opin Genet Dev. 2002 Apr;12(2):162-9 PMID: 11893489
  16. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.
    Clin Cancer Res. 2002 Mar;8(3):641-61 PMID: 11895891
  17. Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects.
    Cancer Res. 2002 Mar 15;62(6):1688-95 PMID: 11912141
  18. Different effects on human topoisomerase I by minor groove and intercalated deoxyguanosine adducts derived from two polycyclic aromatic hydrocarbon diol epoxides at or near a normal cleavage site.
    J Biol Chem. 2002 Apr 19;277(16):13666-72 PMID: 11832494
  19. The Mre11 complex: at the crossroads of dna repair and checkpoint signalling.
    Nat Rev Mol Cell Biol. 2002 May;3(5):317-27 PMID: 11988766
  20. Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin.
    J Biol Chem. 2002 May 10;277(19):17154-60 PMID: 11877436
  21. Mammalian Rad51C contributes to DNA cross-link resistance, sister chromatid cohesion and genomic stability.
    Nucleic Acids Res. 2002 May 15;30(10):2172-82 PMID: 12000837
  22. Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain.
    J Biol Chem. 2002 May 31;277(22):19389-95 PMID: 11901158
  23. Kinetic studies of human tyrosyl-DNA phosphodiesterase, an enzyme in the topoisomerase I DNA repair pathway.
    Eur J Biochem. 2002 Aug;269(15):3697-704 PMID: 12153566
  24. Gemcitabine (2',2'-difluoro-2'-deoxycytidine), an antimetabolite that poisons topoisomerase I.
    Clin Cancer Res. 2002 Aug;8(8):2499-504 PMID: 12171875
  25. Mus81-Eme1 and Rqh1 involvement in processing stalled and collapsed replication forks.
    J Biol Chem. 2002 Sep 6;277(36):32753-9 PMID: 12084712
  26. When machines get stuck--obstructed RNA polymerase II: displacement, degradation or suicide.
    Bioessays. 2002 Sep;24(9):780-4 PMID: 12210513
  27. 8-Oxoguanine rearranges the active site of human topoisomerase I.
    Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12102-7 PMID: 12209008
  28. Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways.
    Oncogene. 2002 Sep 26;21(43):6633-40 PMID: 12242661
  29. Phosphorylation activates Chk1 and is required for checkpoint-mediated cell cycle arrest.
    J Cell Sci. 2002 Dec 1;115(Pt 23):4555-64 PMID: 12415000
  30. NuA4 subunit Yng2 function in intra-S-phase DNA damage response.
    Mol Cell Biol. 2002 Dec;22(23):8215-25 PMID: 12417725
  31. CHK1-regulated S-phase checkpoint response reduces camptothecin cytotoxicity.
    Cell Cycle. 2002 Jul-Aug;1(4):267-72 PMID: 12429946
  32. Repair of topoisomerase I covalent complexes in the absence of the tyrosyl-DNA phosphodiesterase Tdp1.
    Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14970-5 PMID: 12397185
  33. The mechanism of topoisomerase I poisoning by a camptothecin analog.
    Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15387-92 PMID: 12426403
  34. Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures.
    J Mol Biol. 2002 Dec 13;324(5):917-32 PMID: 12470949
  35. Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects.
    EMBO J. 2003 Feb 3;22(3):713-23 PMID: 12554671
  36. Non-camptothecin DNA topoisomerase I inhibitors in cancer therapy.
    Curr Top Med Chem. 2003;3(3):305-20 PMID: 12570765
  37. Reduced apoptotic response to camptothecin in CHO cells deficient in XRCC3.
    Carcinogenesis. 2003 Feb;24(2):249-53 PMID: 12584174
  38. Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody.
    J Biol Chem. 2003 Mar 7;278(10):8468-75 PMID: 12493754
  39. RecQ helicases: caretakers of the genome.
    Nat Rev Cancer. 2003 Mar;3(3):169-78 PMID: 12612652
  40. Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide.
    Chem Biol. 2003 Feb;10(2):139-47 PMID: 12618186
  41. Transcription-dependent degradation of topoisomerase I-DNA covalent complexes.
    Mol Cell Biol. 2003 Apr;23(7):2341-50 PMID: 12640119
  42. Structural impact of the leukemia drug 1-beta-D-arabinofuranosylcytosine (Ara-C) on the covalent human topoisomerase I-DNA complex.
    J Biol Chem. 2003 Apr 4;278(14):12461-6 PMID: 12533542
  43. Defective Brca2 influences topoisomerase I activity in mammalian cells.
    Acta Biochim Pol. 2003;50(1):139-44 PMID: 12673354
  44. The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells.
    Int J Oncol. 2003 May;22(5):1169-73 PMID: 12684687
  45. Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation.
    J Biol Chem. 2003 Apr 25;278(17):14806-11 PMID: 12588868
  46. Topoisomerase I-mediated cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine: trapping of topoisomerase I by the O6-methylguanine.
    Cancer Res. 2001 Jan 1;61(1):53-8 PMID: 11196197
  47. The mechanism of Mus81-Mms4 cleavage site selection distinguishes it from the homologous endonuclease Rad1-Rad10.
    Mol Cell Biol. 2003 May;23(10):3487-96 PMID: 12724407
  48. DNA relaxation by human topoisomerase I occurs in the closed clamp conformation of the protein.
    Proc Natl Acad Sci U S A. 2003 May 13;100(10):5640-5 PMID: 12711735
  49. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes.
    J Biol Chem. 2003 May 30;278(22):20303-12 PMID: 12660252
  50. Apoptosis induced by topoisomerase inhibitors.
    Curr Med Chem Anticancer Agents. 2003 Jul;3(4):271-90 PMID: 12769773
  51. Chk1 and Chk2 kinases in checkpoint control and cancer.
    Cancer Cell. 2003 May;3(5):421-9 PMID: 12781359
  52. Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study.
    Cancer Res. 2003 Jun 1;63(11):2782-93 PMID: 12782583
  53. Validation of a novel assay for checkpoint responses: characterization of camptothecin derivatives in Saccharomyces cerevisiae.
    Mutat Res. 2003 Jun 19;527(1-2):37-48 PMID: 12787912
  54. Yeast histone 2A serine 129 is essential for the efficient repair of checkpoint-blind DNA damage.
    EMBO Rep. 2003 Jul;4(7):678-84 PMID: 12792653
  55. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.
    J Biol Chem. 2003 Jun 13;278(24):21767-73 PMID: 12676925
  56. Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation.
    Mol Cancer Res. 2003 Jun;1(8):598-609 PMID: 12805407
  57. Identification and characterization of the human mus81-eme1 endonuclease.
    J Biol Chem. 2003 Jul 4;278(27):25172-8 PMID: 12721304
  58. Slx1-Slx4 is a second structure-specific endonuclease functionally redundant with Sgs1-Top3.
    Genes Dev. 2003 Jul 15;17(14):1768-78 PMID: 12832395
  59. Modulation of human checkpoint kinase Chk1 by the regulatory beta-subunit of protein kinase CK2.
    Oncogene. 2003 Aug 7;22(32):4933-42 PMID: 12902976
  60. An overactivated ATR/CHK1 pathway is responsible for the prolonged G2 accumulation in irradiated AT cells.
    J Biol Chem. 2003 Aug 15;278(33):30869-74 PMID: 12791699
  61. Association of XRCC1 and tyrosyl DNA phosphodiesterase (Tdp1) for the repair of topoisomerase I-mediated DNA lesions.
    DNA Repair (Amst). 2003 Oct 7;2(10):1087-100 PMID: 13679147
  62. Ataxia telangiectasia-mutated protein can regulate p53 and neuronal death independent of Chk2 in response to DNA damage.
    J Biol Chem. 2003 Sep 26;278(39):37782-9 PMID: 12857758
  63. RecQ helicase stimulates both DNA catenation and changes in DNA topology by topoisomerase III.
    J Biol Chem. 2003 Oct 24;278(43):42668-78 PMID: 12909639
  64. Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I.
    Cancer Res. 2003 Nov 1;63(21):7428-35 PMID: 14612542
  65. Repair of and checkpoint response to topoisomerase I-mediated DNA damage.
    Mutat Res. 2003 Nov 27;532(1-2):173-203 PMID: 14643436
  66. Locking the DNA topoisomerase I protein clamp inhibits DNA rotation and induces cell lethality.
    Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13767-72 PMID: 14585933
  67. Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I.
    Cancer Res. 2003 Dec 1;63(23):8203-11 PMID: 14678976
  68. The Bloom's syndrome helicase suppresses crossing over during homologous recombination.
    Nature. 2003 Dec 18;426(6968):870-4 PMID: 14685245
  69. Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase.
    Cancer Chemother Pharmacol. 2004 Feb;53(2):107-15 PMID: 14605862
  70. The involvement of Srs2 in post-replication repair and homologous recombination in fission yeast.
    Nucleic Acids Res. 2004;32(4):1480-91 PMID: 14993467
  71. Enhanced stimulation of chromosomal translocations by radiomimetic DNA damaging agents and camptothecin in Saccharomyces cerevisiae rad9 checkpoint mutants.
    Mutat Res. 2004 Mar 22;547(1-2):123-32 PMID: 15013706
  72. Thirteen-exon-motif signature for vertebrate nuclear and mitochondrial type IB topoisomerases.
    Nucleic Acids Res. 2004;32(7):2087-92 PMID: 15096574
  73. Aprataxin, a novel protein that protects against genotoxic stress.
    Hum Mol Genet. 2004 May 15;13(10):1081-93 PMID: 15044383
  74. Stable down-regulation of human polynucleotide kinase enhances spontaneous mutation frequency and sensitizes cells to genotoxic agents.
    Proc Natl Acad Sci U S A. 2004 May 4;101(18):6905-10 PMID: 15100409
  75. The deubiquitinating enzyme Doa4p protects cells from DNA topoisomerase I poisons.
    J Biol Chem. 2004 May 14;279(20):21271-81 PMID: 14990574
  76. Requirement for three novel protein complexes in the absence of the Sgs1 DNA helicase in Saccharomyces cerevisiae.
    Genetics. 2001 Jan;157(1):103-18 PMID: 11139495
  77. Hippocampal neurons of mice deficient in DNA-dependent protein kinase exhibit increased vulnerability to DNA damage, oxidative stress and excitotoxicity.
    Brain Res Mol Brain Res. 2001 Mar 5;87(2):257-62 PMID: 11245929
  78. A novel genetic screen identifies checkpoint-defective alleles of Schizosaccharomyces pombe chk1.
    Curr Genet. 2001 Jan;38(6):299-306 PMID: 11270571
  79. Uncoupling of 3'-phosphatase and 5'-kinase functions in budding yeast. Characterization of Saccharomyces cerevisiae DNA 3'-phosphatase (TPP1).
    J Biol Chem. 2001 May 4;276(18):15073-81 PMID: 11278831
  80. Genome maintenance mechanisms for preventing cancer.
    Nature. 2001 May 17;411(6835):366-74 PMID: 11357144
  81. Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells.
    Cancer Res. 2001 Aug 1;61(15):5926-32 PMID: 11479235
  82. Design and synthesis of fluorescent substrates for human tyrosyl-DNA phosphodiesterase I.
    Nucleic Acids Res. 2004;32(15):4657-64 PMID: 15333697
  83. Potentiation of cytotoxicity of topoisomerase i poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe.
    Cancer Res. 2004 Sep 15;64(18):6635-44 PMID: 15374978
  84. The ataxia-oculomotor apraxia 1 gene product has a role distinct from ATM and interacts with the DNA strand break repair proteins XRCC1 and XRCC4.
    DNA Repair (Amst). 2004 Nov 2;3(11):1493-502 PMID: 15380105
  85. Position- and orientation-specific enhancement of topoisomerase I cleavage complexes by triplex DNA structures.
    Nucleic Acids Res. 2004;32(17):5163-73 PMID: 15469908
  86. DNA repair by a Rad22-Mus81-dependent pathway that is independent of Rhp51.
    Nucleic Acids Res. 2004;32(18):5570-81 PMID: 15486206
  87. Enhancement of camptothecin-induced topoisomerase I cleavage complexes by the acetaldehyde adduct N2-ethyl-2'-deoxyguanosine.
    Nucleic Acids Res. 2004;32(18):5685-92 PMID: 15498925
  88. Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae.
    Genes Cells. 2001 Aug;6(8):677-87 PMID: 11532027
  89. Human mitochondrial topoisomerase I.
    Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10608-13 PMID: 11526219
  90. Antisense inhibition of Chk2/hCds1 expression attenuates DNA damage-induced S and G2 checkpoints and enhances apoptotic activity in HEK-293 cells.
    FEBS Lett. 2001 Sep 7;505(1):7-12 PMID: 11557032
  91. DNA topoisomerase IIalpha is required for RNA polymerase II transcription on chromatin templates.
    Nature. 2001 Sep 27;413(6854):435-8 PMID: 11574892
  92. Repair of DNA strand breaks by the overlapping functions of lesion-specific and non-lesion-specific DNA 3' phosphatases.
    Mol Cell Biol. 2001 Nov;21(21):7191-8 PMID: 11585902
  93. Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA.
    EMBO J. 1985 May;4(5):1237-43 PMID: 2988941
  94. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes.
    Proc Natl Acad Sci U S A. 1988 Feb;85(4):1060-4 PMID: 2829214
  95. DNA topoisomerase-targeting antitumor drugs can be studied in yeast.
    Proc Natl Acad Sci U S A. 1988 Oct;85(20):7501-5 PMID: 2845409
  96. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.
    Mol Pharmacol. 1988 Dec;34(6):755-60 PMID: 2849043
  97. Enhanced sensitivity to camptothecin in ataxia-telangiectasia cells and its relationship with the expression of DNA topoisomerase I.
    Int J Radiat Biol. 1989 Feb;55(2):217-31 PMID: 2563396
  98. Vaccinia DNA topoisomerase I promotes illegitimate recombination in Escherichia coli.
    Proc Natl Acad Sci U S A. 1989 May;86(10):3489-93 PMID: 2542933
  99. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin.
    Cancer Res. 1989 Sep 15;49(18):5077-82 PMID: 2548710
  100. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells.
    Cancer Res. 1989 Nov 15;49(22):6365-8 PMID: 2553254
  101. Rapid induction of c-fos transcription reveals quantitative linkage of RNA polymerase II and DNA topoisomerase I enzyme activities.
    Cell. 1990 Jan 12;60(1):141-9 PMID: 2153054
  102. DNA-break repair, radioresistance of DNA synthesis, and camptothecin sensitivity in the radiation-sensitive irs mutants: comparisons to ataxia-telangiectasia cells.
    Mutat Res. 1990 Mar;235(2):49-58 PMID: 2308592
  103. Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription.
    Biochemistry. 1990 Jun 12;29(23):5613-9 PMID: 1696837
  104. Camptothecin hypersensitivity in poly(adenosine diphosphate-ribose) polymerase-deficient cell lines.
    Cancer Commun. 1989;1(6):389-94 PMID: 2562007
  105. Hypersensitivity to clinically useful alkylating agents and radiation in poly(ADP-ribose) polymerase-deficient cell lines.
    Cancer Commun. 1990;2(12):401-7 PMID: 1702304
  106. Cross-sensitivity of gamma-ray-sensitive hamster mutants to cross-linking agents.
    Mutat Res. 1991 Sep;255(2):111-21 PMID: 1922147
  107. Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin.
    J Biol Chem. 1991 Oct 25;266(30):20418-23 PMID: 1657924
  108. The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B.
    Cancer Res. 1992 Apr 1;52(7):1823-9 PMID: 1312900
  109. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis.
    Cancer Res. 1993 Apr 15;53(8):1853-61 PMID: 8467505
  110. Hypersensitivity of Cockayne's syndrome cells to camptothecin is associated with the generation of abnormally high levels of double strand breaks in nascent DNA.
    Cancer Res. 1993 May 1;53(9):2012-9 PMID: 7683249
  111. DNA topoisomerase I is involved in both repression and activation of transcription.
    Nature. 1993 Sep 16;365(6443):227-32 PMID: 8396729
  112. Cellular and chromosomal hypersensitivity to DNA crosslinking agents and topoisomerase inhibitors in the radiosensitive Chinese hamster irs mutants: phenotypic similarities to ataxia telangiectasia and Fanconi's anaemia cells.
    Carcinogenesis. 1993 Dec;14(12):2487-94 PMID: 8269616
  113. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways.
    Mol Cell Biol. 1994 Mar;14(3):1815-23 PMID: 8114714
  114. Effects of DNA methylation on topoisomerase I and II cleavage activities.
    J Biol Chem. 1994 Mar 18;269(11):7893-900 PMID: 8132507
  115. Cell cycle analysis of amount and distribution of nuclear DNA topoisomerase I as determined by fluorescence digital imaging microscopy.
    Cytometry. 1995 Feb 1;19(2):134-45 PMID: 7743894
  116. Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives.
    Biochemistry. 1995 May 30;34(21):7200-6 PMID: 7766631
  117. A novel suicide substrate for DNA topoisomerases and site-specific recombinases.
    Nucleic Acids Res. 1995 Aug 11;23(15):2973-9 PMID: 7659520
  118. Single-stranded DNA arising at telomeres in cdc13 mutants may constitute a specific signal for the RAD9 checkpoint.
    Mol Cell Biol. 1995 Nov;15(11):6128-38 PMID: 7565765
  119. DNA recombinase activity of eukaryotic DNA topoisomerase I; effects of camptothecin and other inhibitors.
    Mutat Res. 1995 Sep;337(2):135-45 PMID: 7565862
  120. Camptothecin resistance involving steps subsequent to the formation of protein-linked DNA breaks in human camptothecin-resistant KB cell lines.
    Cancer Res. 1996 Jan 15;56(2):345-53 PMID: 8542590
  121. The anti-cancer drug camptothecin inhibits elongation but stimulates initiation of RNA polymerase II transcription.
    Carcinogenesis. 1996 Jan;17(1):31-5 PMID: 8565133
  122. Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I.
    Nature. 1996 May 2;381(6577):80-2 PMID: 8609994
  123. Human DNA topoisomerase I-mediated cleavages stimulated by ultraviolet light-induced DNA damage.
    J Biol Chem. 1996 Mar 22;271(12):6978-86 PMID: 8636127
  124. Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity.
    J Cell Biol. 1996 Aug;134(3):757-70 PMID: 8707853
  125. Sister chromatid exchange induced by DNA topoisomerases poisons in late replicating heterochromatin: influence of inhibition of replication and transcription.
    Mutat Res. 1996 Jul 22;354(2):195-201 PMID: 8764948
  126. A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases.
    Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11534-9 PMID: 8876170
  127. Targeted disruption of the mouse topoisomerase I gene by camptothecin selection.
    Mol Cell Biol. 1996 Dec;16(12):6804-9 PMID: 8943335
  128. Topoisomerase I enhances TFIID-TFIIA complex assembly during activation of transcription.
    Genes Dev. 1997 Feb 1;11(3):397-407 PMID: 9030691
  129. Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase I.
    J Biol Chem. 1997 Mar 21;272(12):7792-6 PMID: 9065442
  130. Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function.
    Cancer Res. 1997 Sep 15;57(18):4029-35 PMID: 9307289
  131. Ubiquitin-dependent destruction of topoisomerase I is stimulated by the antitumor drug camptothecin.
    J Biol Chem. 1997 Sep 26;272(39):24159-64 PMID: 9305865
  132. Trapping of mammalian topoisomerase I and recombinations induced by damaged DNA containing nicks or gaps. Importance of DNA end phosphorylation and camptothecin effects.
    J Biol Chem. 1997 Oct 17;272(42):26441-7 PMID: 9334220
  133. Processing of topoisomerase I cleavable complexes into DNA damage by transcription.
    Nucleic Acids Res. 1997 Nov 1;25(21):4181-6 PMID: 9336444
  134. A model for the mechanism of human topoisomerase I.
    Science. 1998 Mar 6;279(5356):1534-41 PMID: 9488652
  135. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139.
    J Biol Chem. 1998 Mar 6;273(10):5858-68 PMID: 9488723
  136. Ultraviolet-induced DNA damage stimulates topoisomerase I-DNA complex formation in vivo: possible relationship with DNA repair.
    Cancer Res. 1998 Mar 1;58(5):976-84 PMID: 9500459
  137. Mammalian DNA topoisomerase I activity and poisoning by camptothecin are inhibited by simian virus 40 large T antigen.
    Biochemistry. 1998 Mar 17;37(11):3818-23 PMID: 9521701
  138. Unveiling two distinct ribonuclease activities and a topoisomerase activity in a site-specific DNA recombinase.
    Mol Cell. 1998 Apr;1(5):729-39 PMID: 9660956
  139. The CHO XRCC1 mutant, EM9, deficient in DNA ligase III activity, exhibits hypersensitivity to camptothecin independent of DNA replication.
    Mutat Res. 1998 Aug 7;408(2):103-10 PMID: 9739812
  140. Cellular roles of DNA topoisomerases: a molecular perspective.
    Nat Rev Mol Cell Biol. 2002 Jun;3(6):430-40 PMID: 12042765
  141. A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle.
    Curr Biol. 2002 Jun 4;12(11):919-24 PMID: 12062056
  142. Fission yeast chk1 mutants show distinct responses to different types of DNA damaging treatments.
    Genes Cells. 2002 Jul;7(7):663-73 PMID: 12081644
  143. Abrogation of the S phase DNA damage checkpoint results in S phase progression or premature mitosis depending on the concentration of 7-hydroxystaurosporine and the kinetics of Cdc25C activation.
    J Biol Chem. 2002 Jul 19;277(29):26553-64 PMID: 11953432
  144. Conversion of phosphoglycolate to phosphate termini on 3' overhangs of DNA double strand breaks by the human tyrosyl-DNA phosphodiesterase hTdp1.
    J Biol Chem. 2002 Jul 26;277(30):27162-8 PMID: 12023295
  145. Chk1 signaling pathways that mediated G(2)M checkpoint in relation to the cellular resistance to the novel topoisomerase I poison BNP1350.
    Biochem Biophys Res Commun. 2002 Jul 12;295(2):435-44 PMID: 12150968
  146. The topoisomerase-related function gene TRF4 affects cellular sensitivity to the antitumor agent camptothecin.
    J Biol Chem. 1999 Mar 12;274(11):7302-8 PMID: 10066793
  147. Werner syndrome lymphoblastoid cells are sensitive to camptothecin-induced apoptosis in S-phase.
    Hum Genet. 1999 Jan;104(1):10-4 PMID: 10071186
  148. Crystal structure of a phospholipase D family member.
    Nat Struct Biol. 1999 Mar;6(3):278-84 PMID: 10074947
  149. Induction of reversible complexes between eukaryotic DNA topoisomerase I and DNA-containing oxidative base damages. 7, 8-dihydro-8-oxoguanine and 5-hydroxycytosine.
    J Biol Chem. 1999 Mar 26;274(13):8516-23 PMID: 10085084
  150. Association of Chk1 with 14-3-3 proteins is stimulated by DNA damage.
    Genes Dev. 1999 Mar 15;13(6):675-85 PMID: 10090724
  151. Human DNA topoisomerase I-mediated cleavage and recombination of duck hepatitis B virus DNA in vitro.
    Nucleic Acids Res. 1999 Apr 15;27(8):1919-25 PMID: 10101202
  152. Acetylation of histone H4 by Esa1 is required for DNA double-strand break repair.
    Nature. 2002 Sep 26;419(6905):411-5 PMID: 12353039
  153. Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy.
    Nat Genet. 2002 Oct;32(2):267-72 PMID: 12244316
  154. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription.
    EMBO J. 2002 Oct 1;21(19):5195-205 PMID: 12356735
  155. Phosphorylation of chk1 at serine-345 affected by topoisomerase I poison SN-38.
    Int J Oncol. 2002 Nov;21(5):1059-66 PMID: 12370755
  156. Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damage.
    Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13669-74 PMID: 12368472
  157. Molecular cloning of the human gene, PNKP, encoding a polynucleotide kinase 3'-phosphatase and evidence for its role in repair of DNA strand breaks caused by oxidative damage.
    J Biol Chem. 1999 Aug 20;274(34):24176-86 PMID: 10446192
  158. Molecular characterization of a human DNA kinase.
    J Biol Chem. 1999 Aug 20;274(34):24187-94 PMID: 10446193
  159. Plasmid linking number change induced by topoisomerase I-mediated DNA damage.
    Nucleic Acids Res. 1999 Jul 15;27(14):2905-11 PMID: 10390532
  160. CDC45 and DPB11 are required for processive DNA replication and resistance to DNA topoisomerase I-mediated DNA damage.
    Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11440-5 PMID: 10500195
  161. Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes.
    Science. 1999 Oct 15;286(5439):552-5 PMID: 10521354
  162. ATR, Claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage.
    Cell Cycle. 2004 Jul;3(7):941-5 PMID: 15190204
  163. Apoptotic topoisomerase I-DNA complexes induced by staurosporine-mediated oxygen radicals.
    J Biol Chem. 2004 Nov 26;279(48):50499-504 PMID: 15448130
  164. Differential impact of diverse anticancer chemotherapeutics on the Cdc25A-degradation checkpoint pathway.
    Exp Cell Res. 2005 Jan 15;302(2):162-9 PMID: 15561098
  165. Apoptotic topoisomerase I-DNA complexes induced by oxygen radicals and mitochondrial dysfunction.
    Cell Cycle. 2004 Sep;3(9):1095-7 PMID: 15326388
  166. Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I.
    Cancer Res. 1989 Sep 15;49(18):5016-22 PMID: 2548707
  167. TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II.
    J Biol Chem. 2004 Dec 31;279(53):55618-25 PMID: 15494395
  168. Interaction of 14-3-3 protein with Chk1 affects localization and checkpoint function.
    J Cell Sci. 2005 Jan 1;118(Pt 1):39-50 PMID: 15585577
  169. The Plk3-Cdc25 circuit.
    Oncogene. 2005 Jan 10;24(2):299-305 PMID: 15640846
  170. Novel function of the flap endonuclease 1 complex in processing stalled DNA replication forks.
    EMBO Rep. 2005 Jan;6(1):83-9 PMID: 15592449
  171. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.
    J Biol Chem. 2005 Jan 14;280(2):1186-92 PMID: 15533933
  172. Deficiency in 3'-phosphoglycolate processing in human cells with a hereditary mutation in tyrosyl-DNA phosphodiesterase (TDP1).
    Nucleic Acids Res. 2005;33(1):289-97 PMID: 15647511
  173. Mechanistically distinct roles for Sgs1p in checkpoint activation and replication fork maintenance.
    EMBO J. 2005 Jan 26;24(2):405-17 PMID: 15616582
  174. The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair.
    Nat Cell Biol. 2005 Feb;7(2):195-201 PMID: 15665856
  175. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation.
    Oncogene. 2005 Feb 17;24(8):1403-11 PMID: 15608676
  176. The novel human gene aprataxin is directly involved in DNA single-strand-break repair.
    Cell Mol Life Sci. 2005 Feb;62(4):485-91 PMID: 15719174
  177. TTK/hMps1 participates in the regulation of DNA damage checkpoint response by phosphorylating CHK2 on threonine 68.
    J Biol Chem. 2005 Mar 4;280(9):7748-57 PMID: 15618221
  178. Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.
    Cell Cycle. 2005 Jan;4(1):166-71 PMID: 15611664
  179. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1.
    Nature. 2005 Mar 3;434(7029):108-13 PMID: 15744309
  180. Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery.
    Trends Pharmacol Sci. 2005 Mar;26(3):138-45 PMID: 15749159
  181. Regulation of CHK2 by DNA-dependent protein kinase.
    J Biol Chem. 2005 Mar 25;280(12):12041-50 PMID: 15668230
  182. Friction and torque govern the relaxation of DNA supercoils by eukaryotic topoisomerase IB.
    Nature. 2005 Mar 31;434(7033):671-4 PMID: 15800630
  183. Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex.
    J Med Chem. 2005 Apr 7;48(7):2336-45 PMID: 15801827
  184. The role of checkpoint kinase 1 in sensitivity to topoisomerase I poisons.
    J Biol Chem. 2005 Apr 8;280(14):14349-55 PMID: 15699047
  185. The S phase checkpoint: when the crowd meets at the fork.
    Semin Cell Dev Biol. 2005 Jun;16(3):355-68 PMID: 15840444
  186. Molecular interaction map of the p53 and Mdm2 logic elements, which control the Off-On switch of p53 in response to DNA damage.
    Biochem Biophys Res Commun. 2005 Jun 10;331(3):816-27 PMID: 15865937
  187. The Plk1 Polo box domain mediates a cell cycle and DNA damage regulated interaction with Chk2.
    Cell Cycle. 2005 Apr;4(4):609-17 PMID: 15876876
  188. Distinct roles for p53 transactivation and repression in preventing UCN-01-mediated abrogation of DNA damage-induced arrest at S and G2 cell cycle checkpoints.
    Oncogene. 2005 May 26;24(23):3786-96 PMID: 15782134
  189. Substrate specificity of tyrosyl-DNA phosphodiesterase I (Tdp1).
    J Biol Chem. 2005 Jun 10;280(23):22029-35 PMID: 15811850
  190. Breaks in coordination: DNA repair in inherited ataxia.
    Neuron. 2005 Jun 16;46(6):845-8 PMID: 15953413
  191. SCAN1 mutant Tdp1 accumulates the enzyme--DNA intermediate and causes camptothecin hypersensitivity.
    EMBO J. 2005 Jun 15;24(12):2224-33 PMID: 15920477
  192. Defects in SUMO (small ubiquitin-related modifier) conjugation and deconjugation alter cell sensitivity to DNA topoisomerase I-induced DNA damage.
    J Biol Chem. 2005 Jun 24;280(25):23566-75 PMID: 15817450
  193. Multiple endonucleases function to repair covalent topoisomerase I complexes in Saccharomyces cerevisiae.
    Genetics. 2005 Jun;170(2):591-600 PMID: 15834151
  194. Human DNA topoisomerase I: relaxation, roles, and damage control.
    Chromosoma. 2005 Jul;114(2):75-85 PMID: 15830206
  195. Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis.
    J Med Chem. 2005 Jul 28;48(15):4803-14 PMID: 16033260
  196. Interfacial inhibitors of protein-nucleic acid interactions.
    Curr Med Chem Anticancer Agents. 2005 Jul;5(4):421-9 PMID: 16101492
  197. Targeting chk2 kinase: molecular interaction maps and therapeutic rationale.
    Curr Pharm Des. 2005;11(22):2855-72 PMID: 16101442
  198. Disruption of murine Mus81 increases genomic instability and DNA damage sensitivity but does not promote tumorigenesis.
    Mol Cell Biol. 2005 Sep;25(17):7569-79 PMID: 16107704
  199. The fission yeast Crb2/Chk1 pathway coordinates the DNA damage and spindle checkpoint in response to replication stress induced by topoisomerase I inhibitor.
    Mol Cell Biol. 2005 Sep;25(17):7889-99 PMID: 16107732
  200. Geldanamycin-induced degradation of Chk1 is mediated by proteasome.
    Biochem Biophys Res Commun. 2005 Sep 30;335(3):900-5 PMID: 16099423
  201. Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway.
    Mol Cell. 2005 Sep 2;19(5):607-18 PMID: 16137618
  202. Activation of DNA damage signaling.
    Mutat Res. 2005 Sep 4;577(1-2):203-16 PMID: 15922368
  203. Reduction of nucleosome assembly during new DNA synthesis impairs both major pathways of double-strand break repair.
    Nucleic Acids Res. 2005;33(15):4928-39 PMID: 16141196
  204. Mechanisms of camptothecin resistance by human topoisomerase I mutations.
    J Mol Biol. 2004 Jun 11;339(4):773-84 PMID: 15165849
  205. Oxidative DNA damage background estimated by a system model of base excision repair.
    Free Radic Biol Med. 2004 Aug 1;37(3):422-7 PMID: 15223076
  206. Chk1 in the DNA damage response: conserved roles from yeasts to mammals.
    DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1025-32 PMID: 15279789
  207. Claspin, a regulator of Chk1 in DNA replication stress pathway.
    DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1033-7 PMID: 15279790
  208. The Chk2 protein kinase.
    DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1039-47 PMID: 15279791
  209. Topoisomerase I-DNA complexes contribute to arsenic trioxide-induced apoptosis.
    J Biol Chem. 2004 Aug 6;279(32):33968-75 PMID: 15178684
  210. Induction of topoisomerase I cleavage complexes by 1-beta -D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells.
    Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1885-90 PMID: 10677551
  211. Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages.
    Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2040-5 PMID: 10688881
  212. DNA damage-induced activation of p53 by the checkpoint kinase Chk2.
    Science. 2000 Mar 10;287(5459):1824-7 PMID: 10710310
  213. Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5'-phosphorylated DNA double-strand breaks by replication runoff.
    Mol Cell Biol. 2000 Jun;20(11):3977-87 PMID: 10805740
  214. Mechanism of caffeine-induced checkpoint override in fission yeast.
    Mol Cell Biol. 2000 Jun;20(12):4288-94 PMID: 10825192
  215. Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice.
    Genes Dev. 2000 Jun 15;14(12):1439-47 PMID: 10859163
  216. Effects of camptothecin on RNA synthesis in leukemia L1210 cells.
    Biochim Biophys Acta. 1971 Aug 26;246(2):225-32 PMID: 5167295
  217. Studies on camptothecin. I. Effects of nucleic acid and protein synthesis.
    Mol Pharmacol. 1971 Nov;7(6):632-44 PMID: 4948241
  218. Effects of deoxyribonucleic acid-reactive drugs on ribonucleic acid synthesis in leukemia L1210 cells.
    Mol Pharmacol. 1972 Sep;8(5):551-60 PMID: 4117298
  219. New views of the biochemistry of eucaryotic DNA replication revealed by aphidicolin, an unusual inhibitor of DNA polymerase alpha.
    Cell. 1981 Mar;23(3):647-8 PMID: 6784928
  220. Cytotoxicity and sister chromatid exchanges induced in vitro by six anticancer drugs developed in the People's Republic of China.
    J Natl Cancer Inst. 1983 Oct;71(4):841-7 PMID: 6413744
  221. Recombinogenic flap ligation pathway for intrinsic repair of topoisomerase IB-induced double-strand breaks.
    Mol Cell Biol. 2000 Nov;20(21):8059-68 PMID: 11027276
  222. swi1 and swi3 perform imprinting, pausing, and termination of DNA replication in S. pombe.
    Cell. 2000 Sep 15;102(6):745-51 PMID: 11030618
  223. Topoisomerase I-mediated DNA damage.
    Adv Cancer Res. 2001;80:189-216 PMID: 11034544
  224. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation.
    Cancer Res. 2000 Nov 1;60(21):5934-6 PMID: 11085506
  225. Werner's syndrome cell lines are hypersensitive to camptothecin-induced chromosomal damage.
    Mutat Res. 2000 Nov 30;456(1-2):45-57 PMID: 11087895
  226. Active DNA topoisomerase IIalpha is a component of the salt-stable centrosome core.
    J Biol Chem. 2000 Dec 8;275(49):38823-30 PMID: 11006289
  227. Mechanisms of DNA topoisomerase I-induced cell killing in the yeast Saccharomyces cerevisiae.
    Ann N Y Acad Sci. 2000;922:65-75 PMID: 11193926
  228. Rapid chromatin reorganization induced by topoisomerase I-mediated DNA damage.
    Ann N Y Acad Sci. 2000;922:340-2 PMID: 11193917
  229. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme.
    Biochim Biophys Acta. 1998 Oct 1;1400(1-3):83-105 PMID: 9748515
  230. Induction of topoisomerase I cleavage complexes by the vinyl chloride adduct 1,N6-ethenoadenine.
    J Biol Chem. 1998 Oct 16;273(42):27245-9 PMID: 9765247
  231. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity.
    Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13097-102 PMID: 9789047
  232. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase.
    Science. 1998 Dec 4;282(5395):1893-7 PMID: 9836640
  233. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells.
    Clin Cancer Res. 1997 Sep;3(9):1653-60 PMID: 9815856
  234. Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes.
    EMBO J. 1999 Mar 1;18(5):1397-406 PMID: 10064605
  235. Phosphorylation of BLM, dissociation from topoisomerase IIIalpha, and colocalization with gamma-H2AX after topoisomerase I-induced replication damage.
    Mol Cell Biol. 2005 Oct;25(20):8925-37 PMID: 16199871
  236. Human Tdp1 cleaves a broad spectrum of substrates, including phosphoamide linkages.
    J Biol Chem. 2005 Oct 28;280(43):36518-28 PMID: 16141202
  237. Genetic analysis of Saccharomyces cerevisiae H2A serine 129 mutant suggests a functional relationship between H2A and the sister-chromatid cohesion partners Csm3-Tof1 for the repair of topoisomerase I-induced DNA damage.
    Genetics. 2006 Jan;172(1):67-76 PMID: 16219777
  238. Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms.
    Science. 1999 Nov 5;286(5442):1166-71 PMID: 10550056
  239. The isolation and genetic analysis of V79-derived etoposide sensitive Chinese hamster cell mutants: two new complementation groups of etoposide sensitive mutants.
    Mutat Res. 1999 Dec 7;435(3):271-82 PMID: 10606818
  240. Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae.
    Cancer Res. 2000 Jan 15;60(2):328-33 PMID: 10667584
  241. Purification and characterization of human DNA topoisomerase IIIalpha.
    Nucleic Acids Res. 1999 Jun 15;27(12):2443-50 PMID: 10352172
  242. Immortalization and characterization of Nijmegen Breakage syndrome fibroblasts.
    Mutat Res. 1999 May 14;434(1):17-27 PMID: 10377945
  243. The topoisomerase I poison camptothecin generates a Chk1-dependent DNA damage checkpoint signal in fission yeast.
    Yeast. 1999 Jul;15(10A):821-8 PMID: 10407262
  244. Caspase-dependent and -independent death of camptothecin-treated embryonic cortical neurons.
    J Neurosci. 1999 Aug 1;19(15):6235-47 PMID: 10414953
  245. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway.
    Oncogene. 1999 Jul 15;18(28):4047-54 PMID: 10435585
  246. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.
    Genes Dev. 2000 Jun 15;14(12):1448-59 PMID: 10859164
  247. Essential functions of DNA topoisomerase I in Drosophila melanogaster.
    Dev Biol. 2000 Jun 1;222(1):27-40 PMID: 10885744
  248. MPH1, a yeast gene encoding a DEAH protein, plays a role in protection of the genome from spontaneous and chemically induced damage.
    Genetics. 2000 Jul;155(3):1069-81 PMID: 10880470
  249. Isolation of camptothecin-sensitive chinese hamster cell mutants: phenotypic heterogeneity within the ataxia telangiectasia-like XRCC8 (irs2) complementation group.
    Mutagenesis. 2000 Jul;15(4):367-74 PMID: 10887218
  250. Position-specific trapping of topoisomerase I-DNA cleavage complexes by intercalated benzo[a]- pyrene diol epoxide adducts at the 6-amino group of adenine.
    Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10739-44 PMID: 10995470
Article Info
Journal
Progress in nucleic acid research and molecular biology
Abbr.
Prog Nucleic Acid Res Mol Biol
ISSN
0079-6603
DOI
10.1016/S0079-6603(06)81005-6
Published
2006-00-00
Pages
179-229
Language
English
Region
United States
NLM ID
0102753
PMCID
PMC2576451
Subset
IM
Grants
Intramural NIH HHS · Z99 CA999999 · United States
External Links
PubMed source DOI: 10.1016/S0079-6603(06)81005-6 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2